BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martens MAG, Filippini N, Harmer CJ, Godlewska BR. Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder. Psychopharmacology (Berl) 2021. [PMID: 34477887 DOI: 10.1007/s00213-021-05915-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Piani MC, Maggioni E, Delvecchio G, Brambilla P. Sustained attention alterations in Major Depressive Disorder: a review of fMRI studies employing Go/No-Go and CPT tasks. J Affect Disord 2022:S0165-0327(22)00144-6. [PMID: 35139418 DOI: 10.1016/j.jad.2022.02.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gerlach AR, Karim HT, Peciña M, Ajilore O, Taylor WD, Butters MA, Andreescu C. MRI predictors of pharmacotherapy response in major depressive disorder. NeuroImage: Clinical 2022;36:103157. [DOI: 10.1016/j.nicl.2022.103157] [Reference Citation Analysis]
3 Kuburi S, Di Passa A, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review. Chronic Stress 2022;6:247054702211153. [DOI: 10.1177/24705470221115342] [Reference Citation Analysis]